EvoNext Holdings S.A. (ELVAF) Research

EvoNext Holdings SA focuses on the discovery, refinement, and market introduction of innovative components for nutritional, healthcare, and general wellness applications. This enterprise was established in 2004 by Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith, and maintains its primary base of operations in Reinach, Switzerland.

Market snapshot

Symbol
ELVAF
Price
$1.10
Day change
0.00%
Market cap
$11.5M
P/E ratio
-17.68x
52-week range
0.9-1.17
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • Avicanna Inc. (AVCNF)
  • Bonus BioGroup Ltd. (BBIXF)
  • Celyad Oncology S.A. (CLYYF)
  • Finch Therapeutics Group, Inc. (FNCH)
  • Hadasit Bio-Holdings Ltd (HSITF)
  • Institute of Biomedical Research Corp. (MRES)
  • Positron Corporation (POSC)
  • Resverlogix Corp. (RVXCF)

Open EvoNext Holdings S.A. (ELVAF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.